Oncology & Cancer

Hydrochlorothiazide tied to non-melanoma skin cancer risk

(HealthDay)—Use of the diuretic hydrochlorothiazide is associated with a substantially increased risk of non-melanoma skin cancer, according to a study published in the April issue of the Journal of the American Academy ...

Medications

Odomzo approved for recurring basal cell carcinoma

(HealthDay)—Odomzo (sonidegib) has been approved by the U.S. Food and Drug Administration to treat basal cell carcinoma skin cancer that has returned despite surgery or radiation.

Oncology & Cancer

Scientists identify promising new melanoma drug

A new drug discovered by scientists at Sanford Burnham Prebys Medical Discovery Institute (SBP) may show promise for treating skin cancers that are resistant or unresponsive to today's leading therapies.

Oncology & Cancer

Check yourself for signs of skin cancer, doctors advise

(HealthDay)—Many busy parents take the time to slather sunscreen on their children before heading outdoors, but they may neglect to protect their own skin. Dermatologists caution that skin cancer can affect anyone—even ...

page 33 from 40